Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Clinical trial NCT05090410 · UNKNOWN
Trial details
- NCT number
- NCT05090410
- Sponsor
- Atsushi Kawakami
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-03
- Primary completion
- 2023-02-28
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.